Target Price | $3.31 |
Price | $0.89 |
Potential |
274.21%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Seres Therapeutics Inc 2025 .
The average Seres Therapeutics Inc target price is $3.31.
This is
274.21%
register free of charge
$10.00
1,029.69%
register free of charge
$1.00
12.97%
register free of charge
|
|
A rating was issued by 8 analysts: 5 Analysts recommend Seres Therapeutics Inc to buy, 1 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Seres Therapeutics Inc stock has an average upside potential 2025 of
274.21%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.89 | -0.12 |
61.47% | 86.52% | |
P/E | negative |
5 Analysts have issued a Seres Therapeutics Inc forecast for earnings per share. The average Seres Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Seres Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.